Taysha Gene Therapies, Inc.

TSHANasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

$9.8M

▲ 17.3% YoY

Net Income

-$109.0M

▼ 22.1% YoY

EPS

$-0.34

▲ 5.6% YoY

Cash

$319.8M

▲ 130.0% YoY

FY 2025 · As of 2025-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.